nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoxsuprine—Abdominal distress—Methotrexate—lymphatic system cancer	0.147	0.147	CcSEcCtD
Isoxsuprine—Hypocalcaemia—Fludarabine—lymphatic system cancer	0.0735	0.0735	CcSEcCtD
Isoxsuprine—Ileus—Vincristine—lymphatic system cancer	0.0581	0.0581	CcSEcCtD
Isoxsuprine—Hypocalcaemia—Mitoxantrone—lymphatic system cancer	0.0437	0.0437	CcSEcCtD
Isoxsuprine—Chest pain—Teniposide—lymphatic system cancer	0.0285	0.0285	CcSEcCtD
Isoxsuprine—Tachycardia—Teniposide—lymphatic system cancer	0.0267	0.0267	CcSEcCtD
Isoxsuprine—Hypotension—Teniposide—lymphatic system cancer	0.0255	0.0255	CcSEcCtD
Isoxsuprine—Vomiting—Mechlorethamine—lymphatic system cancer	0.0236	0.0236	CcSEcCtD
Isoxsuprine—Rash—Mechlorethamine—lymphatic system cancer	0.0234	0.0234	CcSEcCtD
Isoxsuprine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0233	0.0233	CcSEcCtD
Isoxsuprine—Nausea—Mechlorethamine—lymphatic system cancer	0.022	0.022	CcSEcCtD
Isoxsuprine—Chest pain—Bleomycin—lymphatic system cancer	0.0184	0.0184	CcSEcCtD
Isoxsuprine—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.0178	0.0178	CcSEcCtD
Isoxsuprine—Vomiting—Teniposide—lymphatic system cancer	0.0174	0.0174	CcSEcCtD
Isoxsuprine—Rash—Teniposide—lymphatic system cancer	0.0172	0.0172	CcSEcCtD
Isoxsuprine—Dermatitis—Teniposide—lymphatic system cancer	0.0172	0.0172	CcSEcCtD
Isoxsuprine—Hypotension—Bleomycin—lymphatic system cancer	0.0165	0.0165	CcSEcCtD
Isoxsuprine—Nausea—Teniposide—lymphatic system cancer	0.0162	0.0162	CcSEcCtD
Isoxsuprine—Chest pain—Carmustine—lymphatic system cancer	0.016	0.016	CcSEcCtD
Isoxsuprine—Vomiting—Fludarabine—lymphatic system cancer	0.0153	0.0153	CcSEcCtD
Isoxsuprine—Rash—Fludarabine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Isoxsuprine—Dermatitis—Fludarabine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Isoxsuprine—Tachycardia—Carmustine—lymphatic system cancer	0.015	0.015	CcSEcCtD
Isoxsuprine—Chest pain—Mitoxantrone—lymphatic system cancer	0.0149	0.0149	CcSEcCtD
Isoxsuprine—Hypotension—Carmustine—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Isoxsuprine—Nausea—Fludarabine—lymphatic system cancer	0.0143	0.0143	CcSEcCtD
Isoxsuprine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.0139	0.0139	CcSEcCtD
Isoxsuprine—Hypotension—Vincristine—lymphatic system cancer	0.0137	0.0137	CcSEcCtD
Isoxsuprine—Hypotension—Mitoxantrone—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Isoxsuprine—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.012	0.012	CcSEcCtD
Isoxsuprine—Vomiting—Bleomycin—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Isoxsuprine—Rash—Bleomycin—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Isoxsuprine—Dermatitis—Bleomycin—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Isoxsuprine—Nausea—Bleomycin—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Isoxsuprine—Dizziness—Carmustine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Isoxsuprine—Vomiting—Carmustine—lymphatic system cancer	0.00977	0.00977	CcSEcCtD
Isoxsuprine—Dizziness—Vincristine—lymphatic system cancer	0.0097	0.0097	CcSEcCtD
Isoxsuprine—Rash—Carmustine—lymphatic system cancer	0.00969	0.00969	CcSEcCtD
Isoxsuprine—Dermatitis—Carmustine—lymphatic system cancer	0.00968	0.00968	CcSEcCtD
Isoxsuprine—Vomiting—Vincristine—lymphatic system cancer	0.00933	0.00933	CcSEcCtD
Isoxsuprine—Rash—Vincristine—lymphatic system cancer	0.00925	0.00925	CcSEcCtD
Isoxsuprine—Dermatitis—Vincristine—lymphatic system cancer	0.00924	0.00924	CcSEcCtD
Isoxsuprine—Nausea—Carmustine—lymphatic system cancer	0.00913	0.00913	CcSEcCtD
Isoxsuprine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00908	0.00908	CcSEcCtD
Isoxsuprine—Rash—Mitoxantrone—lymphatic system cancer	0.00901	0.00901	CcSEcCtD
Isoxsuprine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.009	0.009	CcSEcCtD
Isoxsuprine—Nausea—Vincristine—lymphatic system cancer	0.00871	0.00871	CcSEcCtD
Isoxsuprine—Nausea—Mitoxantrone—lymphatic system cancer	0.00849	0.00849	CcSEcCtD
Isoxsuprine—Chest pain—Methotrexate—lymphatic system cancer	0.00743	0.00743	CcSEcCtD
Isoxsuprine—Hypotension—Methotrexate—lymphatic system cancer	0.00665	0.00665	CcSEcCtD
Isoxsuprine—Dizziness—Methotrexate—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Isoxsuprine—Vomiting—Methotrexate—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Isoxsuprine—Rash—Methotrexate—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Isoxsuprine—Dermatitis—Methotrexate—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Isoxsuprine—Nausea—Methotrexate—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
